ASHLEY BOETTCHER: Open Payments
NPI 1437527892 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$633 in 29 payments from 8 companies in 2025. Trend: 2023 $704 · 2024 $627 · 2025 $633
Food & beverage: $633
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $224 |
| Lilly USA, LLC | 1 | $116 |
| Otsuka America Pharmaceutical, Inc. | 5 | $97 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $65 |
| Exact Sciences Corporation | 3 | $59 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| Corcept Therapeutics | 1 | $16 |
Products named: VRAYLAR, ZEPBOUND, REXULTI, CAPLYTA, The Cologuard Plus Collection Kit, LEQVIO, BREZTRI, Cologuard Collection Kit.
Industry payments across IN — which companies pay providers there.
